Drug intelligence / Profile preview

urtica dioica extract

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

**urtica dioica extract** is a botanical preparation derived from *Urtica dioica* and represents a heterogeneous herbal extract rather than a single defined molecular entity. It has been investigated as a traditional medicine, nutraceutical, and research-stage therapeutic for inflammatory disorders, benign prostatic hyperplasia, neurodegenerative conditions including Parkinson's disease, cardiovascular disorders, and some cancers. Reported bioactive constituents include polyphenols, flavonoids, phenolic acids such as caffeic acid derivatives, carotenoids, fatty acids, and amino acids. Its proposed pharmacology is pleiotropic and includes anti-inflammatory, antioxidant, and tissue-protective effects, with literature describing inhibition or down-modulation of cyclooxygenase activity, nuclear factor kappa B signaling, elastase and collagenase activity, and oxidative stress pathways rather than a single validated primary target. Because extract composition varies by plant part, extraction method, and product, mechanism, formulation, and clinical positioning are not standardized across studies.

Other names
stinging nettle extracturtica dioica leaf extractnettle extract
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL-6 (Interleukin 6)ELANE (Human Neutrophil Elastase)MMP12 (Macrophage Metalloelastase)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on urtica dioica extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on urtica dioica extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call